The incidence of cardiac arrhythmias during exercise stress testing: a focus on patients with severe obesity undergoing sleeve gastrectomy

doi:10.21203/rs.3.rs-1998083/v1

Download PDF

Article

The incidence of cardiac arrhythmias during exercise stress testing: a focus on patients with severe obesity undergoing sleeve gastrectomy

https://doi.org/10.21203/rs.3.rs-1998083/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 03 Jan, 2023

Read the published version in International Journal of Obesity →

You are reading this latest preprint version

Introduction: Obesity is associated with a higher risk of cardiac arrhythmias. Sleeve Gastrectomy (SG) is a common bariatric surgery with beneficial effects on weight loss and comorbidities. The study aimed to investigate the prevalence of arrhythmias during maximal exercise testing in patients with moderate-severe obesity and to evaluate the impact of SG on these arrhythmic events.

Methods: All patients with moderate or severe obesity who were considered suitable candidates for SG between June 2015 and September 2020 were recruited. Each patient underwent three incremental, maximal, ECG-monitored cardiopulmonary exercise test one month before and six and twelve months after SG; the frequency and complexity of ventricular premature beats (VPBs) and atrial premature beats (APBs) have been evaluated during rest, exercise and recovery phases.

Results: 50 patients with severe obesity (BMI 46.39 ±7.89 kg/m2) were included in the study. After SG, patients presented a decreased BMI (34.15 ± 6.25 kg/m2 at six months post-SG and 31.87 ± 5.99 kg/m2 at twelve months post-SG). At six months post-SG, an increase in VPBs, mainly during the recovery phase, was observed. At twelve months post-SG, a reduction in VPBs compared with the six months evaluation was showed.

Conclusion: Although in the early post-surgical phase the risk of exercise-induced arrhythmias may be higher, SG does not seem to increase the occurrence of arrhythmias in the long-term. No life-threating arrhythmias were found during post-SG evaluations.

Bariatric surgery

ventricular arrhythmia

sudden cardiac death

premature beats

exercise-induced arrhythmias

PVB.

The worldwide increasing prevalence of obesity represents a major health burden and is associated with an increased risk for many metabolic and cardiovascular diseases and comorbidities, such as arterial hypertension, coronary artery disease, heart failure and arrhythmias.¹ Bariatric surgery, and in particular laparoscopic Sleeve Gastrectomy (SG), is recognized as a significant treatment option for severe obesity, achieving sustainable weight loss and providing positive effects on different metabolic and cardiovascular conditions.^2–7

The increased cardiac arrhythmic risk associated with obesity has been previously described, particularly regarding atrial fibrillation (AF) and ventricular arrhythmias.^8–10 Obesity has emerged as an independent risk factor for AF, which can be favorably affected by lifestyle interventions leading to weight loss.^11,12 Specifically, bariatric surgery reduces cardiovascular risk factors and results in an improvement of systo-diastolic function with a regression of ventricular hypertrophy.^13,14 Improvement in functional aspects of cardiac alterations after bariatric surgery seems to be associated with a lower incidence of AF but nothing has been described on possible effects on the presence and complexity of ventricular arrhythmias.¹⁵

Obesity is independently associated with increased onset of ectopic ventricular arrhythmia during exercise,¹⁶ however, little is known about the incidence of arrhythmic events (AF, ventricular premature beats (VPBs) and atrial premature beats (APBs)) during exercise testing in patients with severe obesity eligible for bariatric surgery as well as the effect of surgery, and the following weight loss, on exertional arrhythmias. Thus, the purpose of this study is to investigate the prevalence of arrhythmias during maximal exercise testing in patients with severe obesity and to evaluate the impact of bariatric surgery on cardiac arrhythmic risk.

Subjects and protocol

This observational cohort study consecutively recruited all patients affected by moderate-severe obesity, who were considered suitable candidates for SG after multidisciplinary evaluation. The Sports and Exercise Medicine Division of the University Hospital of Padova conducted the study between June 2015 and September 2020. All study participants followed a regionally approved clinical pathway and underwent SG (Veneto Region, resolution n.55/ CR August 4, 2015). This study was performed in accordance with the Declaration of Helsinki and approved by the local ethics committee (128n/AO/21). After obtaining written informed consent, a complete functional evaluation including anthropometric data assessment, medical examination and cardiopulmonary exercise testing was performed one month before and six and twelve months after SG.¹⁷

Patients receiving beta-blocker or other antiarrhythmic therapy and/or those with a history of major arrhythmic conditions were excluded from the study. Further exclusion criteria were the rejection of surgical intervention, psychotropic substance abuse, and cardiovascular/orthopedic diseases, which contraindicated or impaired exercise testing.

Cardiopulmonary Exercise Testing and ECG analysis

Each patient underwent an incremental, ECG-monitored, maximal cardiopulmonary exercise test (Jaeger Masterscreen-CPX, Carefusion). Tests were performed on treadmill (T170 DE, Cosmed), according to the modified Bruce protocol, with an integrated initial 5-min constant speed interval (2.7 km/h). Criteria of exhaustion were a Borg rating of perceived exertion ≥ 18/20 associated with a respiratory exchange ratio > 1.10, and/or a peak heart rate (HR) ≥ 85% of predicted maximal HR, and/or the achievement of a plateau of oxygen uptake (VO₂).

Continues 12-lead ECG monitoring focused on detecting APBs and VPBs during each test phase (i.e. rest, exercise and recovery). Premature beats (PBs) were then categorized according to number, frequency and complexity (isolated or repetitive). QTc was calculated using the Bazett’s formula.

Statistical Analysis

Statistical analyses were performed with Statistical Package for Social Science (SPSS Inc., Version 20, IBM Corporation, Armank, NY). Continuous variables are expressed as mean ± standard deviation or median and interquartile range; comparisons between the same population before and after SG (one month pre-SG, six- and twelve-months post-SG) were performed with the one-way analysis of variance test with Bonferroni correction or Friedman test. Categorical variables are expressed as percentages and comparison between the same population before and after SG was performed with McNemar test. All reported probability values are two-tailed and a value of p < 0.05 was considered statistically significant.

A total of 50 patients with severe obesity (23 men; 27 women, BMI 46.39 ± 7.89 kg/m²) were included in the study, with a mean age of 46.78 ± 12.42 years. At baseline, 13 patients (26%) were affected by type 2 diabetes mellitus and medically treated with oral hypoglycemics, 15 patients (30%) were treated for arterial hypertension and 7 patients (14%) were affected by sleep apnea syndrome. Anthropometric and baseline ECG characteristics of patients at clinical evaluations are shown in Table I.

Six months post-SG

Six months post-SG, patients lost averagely 35.24 ± 11.19 kg, i.e. 25.90 ± 5.34% of body weight, leading to a mean BMI of 34.15 ± 6.25 kg/m². Post-SG, patients presented lower resting HR and QTc with increased exercise test duration (all p < 0.001).

Two patients (4%) presented repetitive APBs and two patients VPBs during pre-surgical evaluation (two patients presented a supraventricular couplet and two patient a ventricular couplet). Three patients (6%) presented repetitive APBs (two patients presented a supraventricular couplet and one patient presented six supraventricular couplets) and seven patients (14%) presented repetitive VPBs (three patients presented a ventricular couplet, one patient presented seven ventricular couplets, two patients presented a ventricular triplet and one patient presented 11 ventricular couplets and a short tract of non-sustained ventricular tachycardia of 7 beats) during post-SG evaluation. No patients presented AF during pre-surgical evaluation while one patient presented AF post-SG. No patients had sustained ventricular tachycardia.

The qualitative and quantitative analysis of the arrhythmic events during the complete test showed significant difference between the evaluations pre-SG and six months post-SG. The prevalence of VPBs was significantly increased during post-SG evaluation, in particular during the recovery phase, both by number of patients with at least one arrhythmic event and by the frequency of arrhythmic events per minute (Table II and Fig. 1).

Twelve months post-SG

At twelve months post-SG evaluation, patients showed further weight loss (31.87 ± 5.99 kg/m²; p < 0.001). No further reductions in HR, QTc, or significant increases in exercise time were evident. Two patients (4%) presented repetitive APBs (two patients presented a supraventricular couplet) and six patients (14%) presented repetitive VPBs (three patients presented a ventricular couplet, two patients presented two ventricular couplets, one patient presented four ventricular couplets). No patients presented AF or ventricular tachycardia. At twelve months post-SG, a reduction in the number of patients who presented at least one arrhythmic event is evident, in particular VPBs during the recovery phase (p = 0.003; Table I). At twelve months post-SG, linear mixed models revealed a significant decrease in VPBs frequency when compared to the six months post-SG evaluation, mainly during the recovery phase (Fig. 1).

We investigated the prevalence of cardiac arrhythmic events in patients with moderate-severe obesity during cardiopulmonary exercise testing before and after SG. To the best of our knowledge, no previous study analyzed the association between patients affected by severe obesity undergoing SG and exercise-induced cardiac arrhythmias. The main outcomes of this study are:

- Six months after SG, patients presented lower HR, QTc interval and higher exercise tolerance. These changes persist twelve months after bariatric surgery.
- Six months after SG, patients presented an increased occurrence of VPBs, mainly during the recovery phase.
- Twelve months after SG, patients showed a reduction in the frequency of VPBs compared to six months post-SG, mainly during recovery phase, similar to the pre-surgical evaluation.

SG and ECG parameters

Patients affected by obesity present usually higher resting HR compared with subjects with normal weight, probably due to a reduction in parasympathetic activity and relative predominance of sympathetic activity.¹⁸ Weight loss after bariatric surgery has been shown to decrease resting HR and affect HR variability.¹⁹ Moreover, several studies showed that patients with obesity have a prolonged QT interval, highlighting the effects of bariatric surgery on reducing QTc.^20–22 In our study, resting HR and QTc interval were found significantly decreased at six months post SG and further changes are not evident one year after bariatric surgery. The relationship between obesity and prolonged ventricular repolarization is not clearly understood and various hypotheses have been proposed. Typical obesity related comorbidities such as insulin resistance, arterial hypertension and obstructive sleep apnea syndrome could be involved in shortening ventricular repolarization parameters.^23–25 All these comorbidities are represented in our study population before SG and their reduction after bariatric surgery could influence the ECG repolarization pattern.

Moreover, patients post SG showed a longer exercise phase when compared to their own pre-SG testing. This data is in accordance with previous study results that showed how patients with severe obesity have a better exercise tolerance six months after bariatric surgery.²⁶ SG has a positive impact on body composition, physical functioning and metabolic parameters, allowing to perform the same workload with less energy expenditure, also due to improved cardiac reserve.²⁷

SG and arrhythmic risk during exercise testing

Our analysis focused on the comparison of arrhythmias during maximal exercise testing before and after SG. It is known that obesity is associated with an increased risk of cardiac arrythmia including AF,^28,29 PBs^10,16 and sudden cardiac death.^30,31 Moreover, several studies showed the importance of weight reduction in patients with obesity for the treatment of AF, while others report little or no effectiveness.^{11,15,32−34} In our study only one patient presented a short-run AF at six months post-SG and none presented an exercise-induced AF, therefore, it was not possible to analyze the effect of SG on this form of arrhythmia. However, P-wave dispersion and QTc dispersion showed to be attenuated after bariatric surgery, indirectly suggesting a reduction in risk of AF, ventricular arrhythmias, and sudden cardiac death.^{20–22, 35,36}

At six months post-SG, despite a major loss of BMI by all patients, an increase in ventricular arrhythmias, mainly during the recovery phases, was showed. The same phenomenon does not seem to be confirmed for the rest and exercise phases. This behaviour seems to contradict some of the evidence on arrhythmias and obesity since an independent association between BMI and exercise-induced ventricular arrhythmias has already been described in a large cohort of patients.¹⁶ Indeed, several hypotheses (anatomical, immunological, hormonal and multifactorial) have attempted to explain why patients with obesity are more prone to arrhythmic onset. Different studies agree that atrial and ventricular ectopy activation could be due to the structural and electrical remodeling that increase the risk of AF and VPBs.^37,38 Moreover, the epicardial fat presents a pro-inflammatory profile, promoting chronic inflammation of the adjacent cardiac tissue, which may potentially increase the risk of ventricular arrhythmias.^31,39 A further hypothesis involves the possible role of leptin in increasing sympathetic activity and reducing vagal tone.⁴⁰ This hormone has been demonstrated to correlate with BMI and it has been associated with an increase in mean arterial blood pressure and HR in animal models, due to alterations in the autonomic nervous system.^41,42

At twelve months post-SG evaluation, an overall reduction in number of patients presenting VPBs and in VPBs/minute, still primarily during the recovery phase, was observed. The prevalence of arrhythmias seems similar to one month pre-SG evaluation. A possible explanation for this increase and subsequent decrease in arrhythmias during the recovery phase could be due to the imbalance between the circulating catecholamines produced during exercise and the raising of vagal tone, responsible for lowering HR after exercise. An attenuated vagal reactivation might be associated with a minor suppression of ventricular activity and more frequent ventricular arrhythmias during recovery. This was also described as an important and independent predictor of increased mortality risk.⁴³ A previous study conducted by our research group showed that during the recovery phase HR decreases more rapidly in patients at six months after SG, when compared to the pre-surgical evaluation.²⁶ In fact, in these patients there is no difference in the maximum HR reached during exercise testing between evaluations pre and post-SG, while the resting HR appears lower at six months after surgery; therefore, a greater vagal effort is required for the complete recovery after exercise.²⁶ Results of the current study are in line with those already described and provide an implementation of data evaluating also cardiovascular adaptations one year after bariatric surgery. Indeed, at twelve months post-SG, the reduction of arrhythmic events during recovery phase might suggest a restoration of sympathetic-vagal balance related to weight loss maintenance and metabolic equilibrium.

Moreover, a further hypothesis could be related to the nutritional alterations that these patients have to undergo in the first period after SG.⁴⁴ In fact, bariatric surgery patients are at risk for deficiency of different nutrients, especially of trace elements, despite taking supplements.^45,46 The transition from strong catabolism during the first period after bariatric surgery to progressive anabolic recovery can cause nutritional alterations such as micronutrient deficiency (e.g. thiamine), intracellular and extracellular electrolyte disturbances (hypophosphatemia, hypokalaemia, hypomagnesemia), fluid imbalance and salt retention even in the cardiac tissue.⁴⁷ Thus, these subjects might be exposed to an increased risk of cardiac arrhythmias, in a similar way to those documented in the "refeeding syndrome".⁴⁸ It is possible that restoring a regular diet and maintaining a stable weight will help to reduce the arrhythmic susceptibility during the first year after surgery.

This study focused on the first twelve months post-SG, a period in which it is observed a larger weight loss and patients have dietary restrictions and limitations on their lifestyle, especially in the first months after bariatric surgery. Thus, future studies should provide a standardized long-term follow-up post-surgery to a wider sample size, to evaluate the arrhythmic burden after more sustained and stable weight loss. Given the lack of studies regarding weight loss and the risk of cardiac arrhythmias, further research is still needed. By way of example, to investigate if the different treatment options for obesity, such as bariatric surgery, pharmaceutical drugs or dietary interventions, have a different influence on the incidence of arrhythmic events. Finally, also the impact of timing, rapidness of metabolic adaptations and treatment phases should be considered by future trials.

This study provides further information about the relationship between severe obesity and arrhythmic risk during maximal exercise testing. SG seems to slightly increase the global occurrence of ventricular arrhythmias at six months after surgery, mainly during the recovery phase. However, at twelve months post-SG the arrhythmogenic susceptibility improves with more stable metabolic conditions returning comparable to the pre-surgical evaluation. Finally, no life-threating arrhythmias were found post-SG, suggesting that bariatric surgery does not represent a risk factor for the onset of relevant arrhythmic events in these patients. Further studies with longer follow-up after surgery considering also the different effect of pharmaceutical drugs or dietary interventions on the incidence of arrhythmic events are needed.

(AF) atrial fibrillation; (APBs) atrial premature beats; (BMI) body mass index; (HR) heart rate; (PBs) premature beats; (SG) sleeve gastrectomy; (VPBs) ventricular premature beats.

Acknowledgements

The authors thank Alessandra Fecchio, MD, and the staff of the Sports and Exercise Medicine Division of the Department of Medicine for the valuable support during patients’ evaluations. This research project is part of the Italian initiative of Exercise is Medicine.

Competing interest

The authors declare that they have no conflict of interest.

Funding

The authors received no specific funding for this work.

Data Availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Authors' contributions

All authors participated in the preparation of the manuscript and approved this submission.

Conceptualization: Marco Vecchiato, Andrea Gasperetti. Data curation: Marco Vecchiato, Daniel Neunhaeuserer, Giulia Quinto, Silvia Bettini. Formal analysis: Marco Vecchiato, Giulia Quinto, Francesca Battista. Investigation: Marco Vecchiato, Daniel Neunhaeuserer, Andrea Gasperetti, Andrea Ermolao. Methodology: Marco Vecchiato, Francesca Battista, Luca Busetto. Project administration: Roberto Vettor, Luca Busetto, Andrea Ermolao. Supervision: Roberto Vettor, Andrea Ermolao. Writing-original draft: Marco Vecchiato. Writing-review and editing: Marco Vecchiato, Daniel Neunhaeuserer, Giulia Quinto, Silvia Bettini, Luca Busetto, Andrea Ermolao.

Bhaskaran K, dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. The Lancet Diabetes & Endocrinology. 2018;6(12):944. doi:10.1016/S2213-8587(18)30288-2
Graham C, Switzer N, Reso A, et al. Sleeve gastrectomy and hypertension: a systematic review of long-term outcomes. Surgical Endoscopy 2018 33:9. 2018;33(9):3001–3007. doi:10.1007/S00464-018-6566-5
O’Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA. Long-term outcomes after bariatric surgery: Fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Annals of Surgery. 2013;257(1):87–94. doi:10.1097/SLA.0B013E31827B6C02
Switzer NJ, Prasad S, Debru E, Church N, Mitchell P, Gill RS. Sleeve Gastrectomy and Type 2 Diabetes Mellitus: a Systematic Review of Long-Term Outcomes. Obesity Surgery 2016 26:7. 2016;26(7):1616–1621. doi:10.1007/S11695-016-2188-Y
Fried M, Yumuk V, Oppert JM, et al. Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery. Obesity Surgery 2013 24:1. 2013;24(1):42–55. doi:10.1007/S11695-013-1079-8
de Luca M, Angrisani L, Himpens J, et al. Indications for Surgery for Obesity and Weight-Related Diseases: Position Statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO). Obes Surg. 2016;26(8):1659–1696. doi:10.1007/S11695-016-2271-4
Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–2693. doi:10.1056/NEJMOA035622
Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients. Journal of Cardiovascular Electrophysiology. 2007;18(2):181–184. doi:10.1111/j.1540-8167.2006.00680.x
Gami AS, Hodge DO, Herges RM, et al. Obstructive Sleep Apnea, Obesity, and the Risk of Incident Atrial Fibrillation. J Am Coll Cardiol. 2007;49(5):565–571. doi:10.1016/J.JACC.2006.08.060
Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity—results of a meta-analysis. American Heart Journal. 2008;155(2):310–315. doi:10.1016/J.AHJ.2007.10.004
Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310(19):2050–2060. doi:10.1001/JAMA.2013.280521
Pathak RK, Middeldorp ME, Meredith M, et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159–2169. doi:10.1016/J.JACC.2015.03.002
Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98(24):1763–1777. doi:10.1136/HEARTJNL-2012-301778
Aggarwal R, Harling L, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H. The Effects of Bariatric Surgery on Cardiac Structure and Function: a Systematic Review of Cardiac Imaging Outcomes. Obesity Surgery 2015 26:5. 2015;26(5):1030–1040. doi:10.1007/S11695-015-1866-5
Jamaly S, Carlsson L, Peltonen M, Jacobson P, Sjöström L, Karason K. Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects. J Am Coll Cardiol. 2016;68(23):2497–2504. doi:10.1016/J.JACC.2016.09.940
Sabbag A, Sidi Y, Kivity S, et al. Obesity and exercise-induced ectopic ventricular arrhythmias in apparently healthy middle aged adults. European Journal of Preventive Cardiology. 2016;23(5):511–517. doi:10.1177/2047487315591442
Vecchiato M, Neunhaeuserer D, Quinto G, et al. Cardiopulmonary exercise testing in patients with moderate-severe obesity: a clinical evaluation tool for OSA? Sleep and Breathing 2021. 2021;1:1–9. doi:10.1007/S11325-021-02475-0
Rossi RC, Vanderlei LCM, Gonçalves ACCR, et al. Impact of obesity on autonomic modulation, heart rate and blood pressure in obese young people. Autonomic Neuroscience. 2015;193:138–141. doi:10.1016/J.AUTNEU.2015.07.424
Benjamim CJR, Pontes YM de M, de Sousa Junior FW, et al. Does bariatric surgery improve cardiac autonomic modulation assessed by heart rate variability? A systematic review. Surgery for Obesity and Related Diseases. 2021;17(8):1497–1509. doi:10.1016/J.SOARD.2021.03.022
Papaioannou A, Michaloudis D, Fraidakis O, et al. Effects of Weight Loss on QT Interval in Morbidly Obese Patients. Obesity Surgery. 2003;13(6):869–873. doi:10.1381/096089203322618687
Grasser EK, Ernst B, Thurnheer M, Schultes B. QT Interval Shortening After Bariatric Surgery Depends on the Applied Heart Rate Correction Equation. Obesity Surgery. 2017;27(4):973–982. doi:10.1007/S11695-016-2393-8
Al-Salameh A, Allain J, Jacques A, Verhaeghe P, Desailloud R. Shortening of the QT Interval is Observed Soon after Sleeve Gastrectomy in Morbidly Obese Patients. Obesity Surgery 2013 24:1. 2013;24(1):167–170. doi:10.1007/S11695-013-1128-3
Vasheghani M, Sarvghadi F, Beyranvand MR, Emami H. The relationship between QT interval indices with cardiac autonomic neuropathy in diabetic patients: a case control study. Diabetology & Metabolic Syndrome 2020 12:1. 2020;12(1):1–8. doi:10.1186/S13098-020-00609-0
Sökmen E, Özbek SC, Çelik M, Sivri S, Metin M, Avcu M. Changes in the parameters of ventricular repolarization during preapnea, apnea, and postapnea periods in patients with obstructive sleep apnea. Pacing and Clinical Electrophysiology. 2018;41(7):762–766. doi:10.1111/PACE.13365
Drigny J, Gremeaux V, Guiraud T, Gayda M, Juneau M, Nigam A. Long-term high-intensity interval training associated with lifestyle modifications improves QT dispersion parameters in metabolic syndrome patients. Annals of Physical and Rehabilitation Medicine. 2013;56(5):356–370. doi:10.1016/J.REHAB.2013.03.005
Neunhaeuserer D, Gasperetti A, Savalla F, et al. Functional Evaluation in Obese Patients Before and After Sleeve Gastrectomy. Obesity Surgery 2017 27:12. 2017;27(12):3230–3239. doi:10.1007/S11695-017-2763-X
Serés L, Lopez-Ayerbe J, Coll R, et al. Increased Exercise Capacity after Surgically Induced Weight Loss in Morbid Obesity. Obesity. 2006;14(2):273–279. doi:10.1038/OBY.2006.35
Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. J Am Med Assoc. 2004;292(20):2471–2477. doi:10.1001/jama.292.20.2471
Tedrow UB, Conen D, Ridker PM, et al. The Long and Short Term Impact of Elevated Body Mass Index on Risk of New Atrial Fibrillation in the Women’s Health Study. J Am Coll Cardiol. 2010;55(21):2319. doi:10.1016/J.JACC.2010.02.029
Adabag S, Huxley RR, Lopez FL, et al. Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study. Heart. 2015;101(3):215. doi:10.1136/HEARTJNL-2014-306238
Messerli FH, Nunez BD, Ventura HO, Snyder DW. Overweight and Sudden Death: Increased Ventricular Ectopy in Cardiopathy of Obesity. Archives of Internal Medicine. 1987;147(10):1725–1728. doi:10.1001/ARCHINTE.1987.00370100039008
Pathak RK, Middeldorp ME, Meredith M, et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159–2169. doi:10.1016/J.JACC.2015.03.002
Huynh K. Atrial fibrillation: Weight loss reduces AF burden. Nature Reviews Cardiology. 2015;12(5):260. doi:10.1038/nrcardio.2015.50
Alonso A, Bahnson JL, Gaussoin SA, et al. Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: The Look AHEAD randomized trial. American Heart Journal. 2015;170(4):770–777.e5. doi:10.1016/J.AHJ.2015.07.026
Yılmaz M, Altın C, Tekin A, et al. Assessment of Atrial Fibrillation and Ventricular Arrhythmia Risk after Bariatric Surgery by P Wave/QT Interval Dispersion. Obesity Surgery. 2018;28(4):932–938. doi:10.1007/S11695-017-2923-Z
Russo V, Ammendola E, de Crescenzo I, et al. Effect of Weight Loss following Bariatric Surgery on Myocardial Dispersion of Repolarization in Morbidly Obese Patients. Obesity Surgery 2007 17:7. 2007;17(7):857–865. doi:10.1007/S11695-007-9160-9
Wanahita N, Messerli FH, Bangalore S, Gami AS, Somers VK, Steinberg JS. Atrial fibrillation and obesity—results of a meta-analysis. American Heart Journal. 2008;155(2):310–315. doi:10.1016/J.AHJ.2007.10.004
Abed HS, Samuel CS, Lau DH, et al. Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation. Heart Rhythm. 2013;10(1):90–100. doi:10.1016/J.HRTHM.2012.08.043
Packer M. Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium. J Am Coll Cardiol. 2018;71(20):2360–2372. doi:10.1016/J.JACC.2018.03.509
Karason K, Mølgaard H, Wikstrand J, Sjöström L. Heart rate variability in obesity and the effect of weight loss. Am J Cardiol. 1999;83(8):1242–1247. doi:10.1016/S0002-9149(99)00066-1
Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine 1995 1:11. 1995;1(11):1155–1161. doi:10.1038/nm1195-1155
Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic Cardiovascular and Renal Actions of Leptin. Hypertension. 2002;39(2 II):496–501. doi:10.1161/HY0202.104398
Frolkis JP, Pothier CE, Blackstone EH, Lauer MS. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med. 2003;348(9):781–790. doi:10.1056/NEJMOA022353
Bettini S, Belligoli A, Fabris R, Busetto L. Diet approach before and after bariatric surgery. Rev Endocr Metab Disord. 2020;21(3):297–306. doi:10.1007/S11154-020-09571-8
Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition. 2010;26(11–12):1031–1037. doi:10.1016/J.NUT.2009.12.003
Gasmi A, Bjørklund G, Mujawdiya PK, et al. Micronutrients deficiences in patients after bariatric surgery. Eur J Nutr. 2022;61(1):55–67. doi:10.1007/S00394-021-02619-8
Reber E, Friedli N, Vasiloglou MF, Schuetz P, Stanga Z. Management of Refeeding Syndrome in Medical Inpatients. Journal of Clinical Medicine. 2019;8(12). doi:10.3390/JCM8122202
Chiappetta S, Stein J. Refeeding Syndrome: An Important Complication Following Obesity Surgery. Obesity Facts. 2016;9(1):12. doi:10.1159/000442534

Table I. Clinical characteristics and ECG measurements of patients with severe obesity (n=50) one month before, six months and twelve months after sleeve gastrectomy (SG).

n = 50	1 month pre-SG	6 months post-SG	12 months post-SG	p
Age (years)	46.78 ± 12.42	47.29 ± 12.09	48.11 ± 14.19	-
Weight (kg)	133.82 ± 32.10	98.58 ± 25.16	92.10 ± 24.23	<0.001 ^a,b
BMI (kg/m2)	46.39 ± 7.89	34.15 ± 6.25	31.87 ± 5.99	<0.001 ^a,b
HR (bpm)	78.64 ± 12.04	62.64 ± 9.55	64.14 ± 9.84	<0.001 ^a,b
Axis (°)	60.00 (38.75 - 66.25)	60.00 (40.00 - 65.00)	60.00 (50.00 – 75.00)	0.086
PQ (ms)	160 (140 – 180)	160 (140 – 165)	160 (140 – 180)	0.462
QTc (ms)	411.72 ± 19.30	387.92 ± 50.86	385.72 ± 61.94	<0.001^a,b
Exercise duration (s)	742.36 ± 182.07	890.62 ± 205.39	909.60 ± 209.64	<0.001^a,b

a: p < 0.05 between one month pre-SG and six months post-SG;
b: p < 0.05 between one month pre-SG and twelve months post-SG;

Continuous variables are expressed as mean ± standard deviation or median and interquartile range.

APBs = atrial premature beats; BMI = body mass index; HR = heart rate; VPBs = ventricular premature beats.

Table II. Analyses of the arrhythmic events during maximal exercise testing one month before, six and twelve months after sleeve gastrectomy (SG) in 50 patients with severe obesity.

n = 50	1 month pre-SG	6 months post-SG	12 months post-SG	p
*Complete test*
PBs (%)	30 (60)	37 (74)	34 (68)	0.326
APBs (%)	13 (26)	21 (42)	19 (38)	0.219
Repetitive APBs (%)	2 (4)	3 (6)	2 (4)	0.861
VPBs (%)	22 (44)	30 (60)	22 (44)	0.181
Repetitive VPBs (%)	2 (4)	7 (14)	6 (12)	0.174
*Rest*
PBs (%)	4 (8)	4 (8)	4 (8)	-
APBs (%)	1 (2)	1 (2)	1 (2)	-
VPBs (%)	3 (6)	3 (6)	3 (6)	-
*Exercise*
PBs (%)	24 (48)	29 (58)	24 (48)	0.513
APBs (%)	12 (24)	17 (34)	15 (30)	0.543
VPBs (%)	19 (38)	19 (38)	16 (32)	0.771
*Recovery*
PBs (%)	14 (28)	25 (50)	15 (30)	0.040
APBs (%)	6 (12)	12 (24)	6 (12)	0.168
VPBs (%)	8 (16)	22 (44)	10 (20)	0.003

Variables are expressed as frequencies (percentage).

APBs = atrial premature beats; PBs = premature beats; VPBs = ventricular premature beats.

There is NO conflict of interest to disclose

Download PDF

Journal Publication

published 03 Jan, 2023

Read the published version in International Journal of Obesity →

Editorial decision: revise
14 Nov, 2022
Review #2 received at journal
06 Nov, 2022
Reviewer #2 agreed at journal
26 Oct, 2022
Review #1 received at journal
27 Sep, 2022
Reviewer #1 agreed at journal
10 Sep, 2022
Reviewers invited by journal
10 Sep, 2022
Submission checks completed at journal
25 Aug, 2022
Editor assigned by journal
25 Aug, 2022
First submitted to journal
25 Aug, 2022

You are reading this latest preprint version

The incidence of cardiac arrhythmias during exercise stress testing: a focus on patients with severe obesity undergoing sleeve gastrectomy

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Material And Methods

Subjects and protocol

Cardiopulmonary Exercise Testing and ECG analysis

Statistical Analysis

Results

Six months post-SG

Twelve months post-SG

Discussion

SG and ECG parameters

SG and arrhythmic risk during exercise testing

Limitations And Perspectives

Conclusion

Abbreviations

Declarations

References

Tables

Additional Declarations

Status:

Journal Publication

Version 1